“Partnering boosted fuel sales at targeted sites — and helped support frontline staff.”


In a bold stride toward transforming cancer care, NHS England has begun rolling out a cutting-edge digital platform known as Cancer 360—an innovation poised to dramatically speed up diagnosis times and improve coordination across the entire cancer treatment pathway.
This all-in-one system is designed to integrate and streamline patient data, giving clinicians a clearer, more comprehensive view of each individual’s case. By doing so, Cancer 360 allows teams to make faster, better-informed decisions—potentially saving lives while reducing strain on overstretched services.
Delays in cancer diagnosis can have devastating consequences. The earlier a cancer is detected, the higher the chances of successful treatment and long-term survival. However, in many parts of the UK, patients have faced lengthy waits for scans, specialist referrals, and follow-up appointments, often due to disjointed data systems and overwhelmed care pathways.
Cancer 360 addresses these challenges by creating a centralised digital hub that brings together medical records, test results, referral information, and clinical notes—all in real-time. Instead of sifting through multiple platforms or chasing updates across departments, clinicians now have a single, unified interface from which they can access everything they need to progress a case.
Initial trials of Cancer 360 at several NHS Trusts—including Chelsea and Westminster Hospital—have yielded impressive results. These pilot sites have already succeeded in meeting the NHS’s 28-day Faster Diagnosis Standard, a key performance metric aimed at ensuring patients receive a definitive diagnosis (or ruling out of cancer) within four weeks of referral.
According to clinicians on the front lines, the platform has not only improved efficiency but also helped flag urgent cases that might otherwise be missed. This proactive, data-driven triage system ensures that the most critical patients are prioritised and receive timely care.
Dr. Emma Brookes, a consultant oncologist involved in the programme, commented:
“We’re no longer reacting to paperwork or system delays. Cancer 360 gives us the tools to act quickly, which is exactly what our patients need.”
One of the most significant advantages of Cancer 360 is how it reshapes the patient journey. With diagnostics, referrals, and follow-ups now digitally synchronised, patients experience fewer handovers, reduced waiting times, and far greater transparency about their care.
Furthermore, Cancer 360 supports multidisciplinary team (MDT) coordination, allowing oncologists, radiologists, pathologists, and surgeons to access and discuss patient cases simultaneously—regardless of location. This creates a more cohesive and collaborative care model, ultimately improving clinical outcomes.
NHS England has expressed confidence in scaling the platform nationwide over the coming months. If early successes continue, Cancer 360 could become a cornerstone of the NHS’s long-term plan to modernise cancer services and reduce variation in care quality across the country.
The digital tool also aligns with broader NHS goals around data interoperability, patient empowerment, and the use of artificial intelligence in routine clinical workflows. There are even plans to incorporate predictive analytics in future versions of the system, enabling even earlier identification of patients at risk of cancer.
Cancer 360 represents more than just a software upgrade—it’s a meaningful shift toward faster, smarter, and more compassionate cancer care. By bringing together people, process, and technology, this initiative has the potential to rewrite the story for thousands of patients each year, offering them hope through timely action.
As the NHS continues to adopt data-led solutions, Cancer 360 stands as a beacon of what’s possible when digital transformation is driven by clinical need and patient benefit.
Real reviews from happy clients